A detailed history of Northern Trust Corp transactions in Cor Medix Inc. stock. As of the latest transaction made, Northern Trust Corp holds 458,628 shares of CRMD stock, worth $1.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
458,628
Previous 448,956 2.15%
Holding current value
$1.99 Million
Previous $1.69 Million 15.17%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$2.94 - $4.24 $28,435 - $41,009
9,672 Added 2.15%
458,628 $1.94 Million
Q4 2023

Feb 13, 2024

SELL
$3.0 - $4.01 $6,777 - $9,058
-2,259 Reduced 0.5%
448,956 $1.69 Million
Q3 2023

Nov 13, 2023

BUY
$3.6 - $4.46 $255,031 - $315,955
70,842 Added 18.62%
451,215 $1.67 Million
Q2 2023

Aug 11, 2023

BUY
$3.94 - $5.8 $1.19 Million - $1.75 Million
302,445 Added 388.11%
380,373 $1.51 Million
Q1 2023

May 15, 2023

BUY
$3.22 - $4.61 $21,458 - $30,721
6,664 Added 9.35%
77,928 $322,000
Q3 2022

Nov 14, 2022

BUY
$2.88 - $7.52 $2,845 - $7,429
988 Added 1.41%
71,264 $201,000
Q2 2022

Aug 12, 2022

SELL
$2.73 - $5.61 $691,402 - $1.42 Million
-253,261 Reduced 78.28%
70,276 $283,000
Q1 2022

May 13, 2022

SELL
$3.83 - $6.24 $47,591 - $77,538
-12,426 Reduced 3.7%
323,537 $1.77 Million
Q4 2021

Feb 08, 2022

SELL
$4.47 - $5.56 $32,519 - $40,449
-7,275 Reduced 2.12%
335,963 $1.53 Million
Q3 2021

Nov 15, 2021

SELL
$4.46 - $7.11 $79,307 - $126,430
-17,782 Reduced 4.93%
343,238 $1.6 Million
Q2 2021

Aug 13, 2021

BUY
$6.05 - $10.09 $153,670 - $256,286
25,400 Added 7.57%
361,020 $2.48 Million
Q1 2021

May 12, 2021

SELL
$6.84 - $17.58 $116,355 - $299,053
-17,011 Reduced 4.82%
335,620 $3.35 Million
Q4 2020

Feb 11, 2021

BUY
$5.0 - $9.15 $72,700 - $133,041
14,540 Added 4.3%
352,631 $2.62 Million
Q3 2020

Nov 16, 2020

BUY
$3.96 - $6.15 $38,899 - $60,411
9,823 Added 2.99%
338,091 $2.04 Million
Q2 2020

Aug 14, 2020

BUY
$3.08 - $6.56 $25,000 - $53,247
8,117 Added 2.54%
328,268 $2.07 Million
Q1 2020

May 14, 2020

BUY
$2.35 - $7.08 $60,493 - $182,253
25,742 Added 8.74%
320,151 $1.15 Million
Q4 2019

Feb 14, 2020

SELL
$4.96 - $7.75 $84,419 - $131,905
-17,020 Reduced 5.47%
294,409 $2.14 Million
Q3 2019

Nov 13, 2019

BUY
$6.38 - $9.69 $1.33 Million - $2.02 Million
207,998 Added 201.1%
311,429 $1.99 Million
Q2 2019

Aug 13, 2019

BUY
$5.93 - $10.57 $348,701 - $621,547
58,803 Added 131.76%
103,431 $928,000
Q1 2019

May 13, 2019

BUY
$6.95 - $13.25 $310,164 - $591,321
44,628 New
44,628 $421,000

Others Institutions Holding CRMD

About CorMedix Inc.


  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $178M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.